A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance
โ Scribed by Seth Michelson; Doris Slate
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 788 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1522-9602
No coin nor oath required. For personal study only.
โฆ Synopsis
Cells displaying the classic multidrug resistant (MDR) phenotype possess a transmembrane protein (p170 or P-glycoprotein) which can actively extrude cytotoxic agents from the cytoplasm. A mathematical model of this drug efflux pump has been developed. Outward transport is modeled as a facilitated diffusion process. Since energy-dependent efftux of cytotoxic agents requires that ATP also bind to p170, the model includes a dynamic calculation for elllux rate which considers Michaelis-Menten kinetics for both the substrate agent and ATP. The final system consists of one partial differential equation (PDE) for the facilitated diffusion ofsubstrate agents out of the cell, a 2 ร 2 ordinary differential equation (ODE) system for the dynamic calculation of the ATP-ADP pool, and a dynamic algebraic calculation of the effiux rate given substrate levels at the interior cell membrane interface and ATP levels in the cell. A stability analysis of the ATP-ADP pool distribution and a simplistic closed form solution of the linearized PDE are included. Numerical simulations are also provided.
๐ SIMILAR VOLUMES
BACKGROUND. Despite extensive investigation, the role of MDR of human cancer remains unclear. Canine lymphoma is a spontaneously arising correlate of human non-Hodgkin's lymphoma that may complement other in vivo models for investigation of issues related to MDR. METHODS. Immunoreactivity of primary
A homologue of the multidrug resistance (MDR) gene was obtained while screening a potato stolon tip cDNA expression library with 35S-labeled calmodulin. The mammalian MDR gene codes for a membrane-bound Pglycoprotein (170-180 kDa) which imparts muitidrug resistance to cancerous cells. The potato cDN
For years, P-glycoprotein (P-gp) has been purported to be a membrane transporter capable of selectively transporting many (but not all) lipophilic anticancer drugs with diverse chemical structures. Because the alleged functions of P-gp provide a straightforward, near-perfect explanation for the mole